Covidien has signed its second acquisition agreement of the month, sealing a merger deal with Somanetics worth $250m, net of cash acquired. Somanetics (Troy, Michigan) specialises in cerebral and somatic oximetry and recorded revenue of $50m in 2009, with double-digit sales growth for ...
Please Login to read the full article.
